Lantern Pharma Inc
(LTRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,977 | 18,358 | 21,938 | 25,572 | 28,964 |
| Marketable Securities | 20,286 | 20,000 | 19,365 | 19,354 | 19,526 |
| TOTAL | $35,292 | $39,471 | $43,341 | $47,426 | $51,042 |
| Non-Current Assets | |||||
| PPE Net | 50 | 50 | 52 | 51 | 50 |
| Other Non-Current Assets | 245 | 213 | 254 | 295 | 334 |
| TOTAL | $295 | $263 | $306 | $346 | $384 |
| Total Assets | $35,587 | $39,734 | $43,648 | $47,772 | $51,426 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,437 | 3,775 | 2,505 | 2,085 | 2,853 |
| TOTAL | $4,601 | $3,953 | $2,678 | $2,253 | $3,016 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 55 | 16 | 62 | 107 | 151 |
| TOTAL | $55 | $16 | $62 | $107 | $151 |
| Total Liabilities | $4,656 | $3,969 | $2,740 | $2,360 | $3,167 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,765 | 10,759 | 10,741 | 10,869 | 10,869 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -65,645 | -60,685 | -55,244 | -51,059 | -47,897 |
| Other shareholders' equity | -7 | 2 | -108 | -139 | -262 |
| TOTAL | $30,931 | $35,765 | $40,908 | $45,412 | $48,259 |
| Total Liabilities And Equity | $35,587 | $39,734 | $43,648 | $47,772 | $51,426 |